Aida Pharmaceuticals, Inc.

AIDA · OTC
Analyze with AI
9/30/2008
6/30/2008
3/31/2008
12/31/2007
Operating Activities
Net Income$2,211-$6,777-$19$2,406
Dep. & Amort.$825$683$501$463
Deferred Tax-$1,070-$825-$72$26
Stock-Based Comp.$0$0$0$0
Change in WC-$588$1,218$67-$2,212
Other Non-Cash$770$7,226$134$1,202
Operating Cash Flow$2,148$1,524$611$1,885
Investing Activities
PP&E Inv.-$2,552-$767-$457-$1,482
Net Acquisitions$0$0$0$3
Inv. Purchases$0$0-$381-$6,763
Inv. Sales/Matur.$0$0$0-$18
Other Inv. Act.$734$508-$7,946$4,452
Investing Cash Flow-$1,819-$259-$8,784-$3,811
Financing Activities
Debt Repay.$4,483-$724$4,033$711
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$730-$197$830$1,249
Financing Cash Flow$3,753-$921$4,864$1,960
Forex Effect-$40-$705-$494$672
Net Chg. in Cash$4,043-$361-$3,802$706
Supplemental Information
Beg. Cash$4,235$4,597$8,399$7,693
End Cash$8,278$4,235$4,597$8,399
Free Cash Flow-$404$757$155$403